|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:D4004 Batch: D400403
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.
| CAS No. | 2227102-46-5 |
|---|---|
| Formulation | 1xPBS |
| ADC antiody | Patritumab |
| ADC cytotoxin | Dxd |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 10.45mg/ml |
| Endotoxin Level | <1EU/mg |
| Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer [ JCI Insight, 2025, 10(16)e187151] | PubMed: 40857406 |
人間や獣医の診断であるか治療的な使用のためにでない。